The equity shares of Molbio Diagnostics (Scrip Code: 544866) are listed effective 17 August 2026 and admitted to dealings on the exchange in the list of ''B'' group securities. At 09:22 IST, the pre-open indicative price of the stock was at a premium of Re 1 over the offer price of Rs 807.